In a report released today, Vanessa Jeffriess from Jefferies reiterated a Hold rating on Synthomer (SYNT – Research Report), with a price target of p107.00.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Vanessa Jeffriess’s rating is based on Synthomer’s recent strategic move to divest its non-core inorganic chemistry business, William Blythe, for £30 million. This disposal is seen as a positive step towards reducing the company’s leverage, as it was sold at a higher multiple than anticipated. Despite this beneficial transaction, the business was not currently affecting margins negatively, which suggests a neutral impact on the company’s overall financial health.
Furthermore, Synthomer’s plan to make additional divestments this year, potentially generating around £70 million, supports the Hold rating. These actions indicate a strategic focus on streamlining operations and improving financial stability, yet the overall outlook remains cautious, warranting a Hold rather than a Buy or Sell recommendation.
In another report released on May 2, UBS also maintained a Hold rating on the stock with a p100.00 price target.